Xiaotong Yang
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 15
-
- Advanced biosensing and bioanalysis techniques 4
- Co-authors
- Huile Gao (11 shared papers)Chuan Hu (7 shared papers)Meiyu Geng (1 shared paper)Min Huang (1 shared paper)Fei‐Fei Liu (1 shared paper)Rui Liu (5 shared papers)Lin Qin (5 shared papers)Wei Xiao (2 shared papers)
- Journals
- Acta Pharmaceutica Sinica B (5 papers)Crystal Growth & Design (3 papers)Biomaterials (3 papers)International Journal of Pharmaceutics (3 papers)Advanced Functional Materials (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaotong Yang
57 papers receiving 2.4k citations
Xiaotong Yang's Hit Papers
Peers
Comparison fields: 5 of 146
- Biomaterials 578
- Pharmaceutical Science 211
- Biomedical Engineering 977
- Immunology 271
- Molecular Biology 870
Countries citing papers authored by Xiaotong Yang
This map shows the geographic impact of Xiaotong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotong Yang more than expected).
Fields of papers citing papers by Xiaotong Yang
This network shows the impact of papers produced by Xiaotong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotong Yang. The network helps show where Xiaotong Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaotong Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy Hit paper breakdown → | 2018 | 329 |
| 2 | 2018 | 259 | |
| 3 | 2019 | 184 | |
| 4 | 2019 | 172 | |
| 5 | 2020 | 144 | |
| 6 | 2021 | 144 | |
| 7 | 2021 | 132 | |
| 8 | 2019 | 98 | |
| 9 | 2018 | 97 | |
| 10 | 2021 | 81 | |
| 11 | 2021 | 79 | |
| 12 | 2021 | 65 | |
| 13 | 2020 | 63 | |
| 14 | 2023 | 54 | |
| 15 | 2020 | 52 | |
| 16 | 2021 | 50 | |
| 17 | 2024 | 31 | |
| 18 | 2023 | 30 | |
| 19 | 2022 | 26 | |
| 20 | 2016 | 25 |
About Xiaotong Yang
Xiaotong Yang is a scholar working on Biomedical Engineering, Molecular Biology, Materials Chemistry, Biomaterials and Pharmaceutical Science, having authored 58 papers that have together received 2.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (15 papers), Drug Solubulity and Delivery Systems (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Crystallography and molecular interactions (5 papers), Crystallization and Solubility Studies (5 papers), Corporate Finance and Governance (5 papers), Auditing, Earnings Management, Governance (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Biomaterials (578 citations), Pharmaceutical Science (211 citations), Biomedical Engineering (977 citations), Immunology (271 citations) and Molecular Biology (870 citations). Xiaotong Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Huile Gao, Chuan Hu, Meiyu Geng, Min Huang, Fei‐Fei Liu, Rui Liu, Lin Qin, Wei Xiao, Yang Zhou and Xueqin He. Their work appears in journals such as Acta Pharmaceutica Sinica B, Crystal Growth & Design, Biomaterials, International Journal of Pharmaceutics and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.